Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-23-078767
Filing Date
2023-09-22
Accepted
2023-09-22 16:16:41
Documents
1
Period of Report
2023-09-22

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT pre14a0923_tffpharma.htm PRE 14A 1136589
  Complete submission text file 0001213900-23-078767.txt   1137582
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39102 | Film No.: 231271902
SIC: 2834 Pharmaceutical Preparations